Arvinas, Inc. (ARVN)
7.30
-0.42
(-5.44%)
USD |
NASDAQ |
Oct 23, 16:00
7.28
-0.02
(-0.27%)
Pre-Market: 09:14
Arvinas Market Cap : 476.69M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 476.69M |
| October 22, 2026 | 504.12M |
| October 21, 2026 | 493.34M |
| October 20, 2026 | 500.20M |
| October 19, 2026 | 474.08M |
| October 16, 2026 | 455.14M |
| October 15, 2026 | 467.55M |
| October 14, 2026 | 445.35M |
| October 13, 2026 | 446.65M |
| October 12, 2026 | 486.48M |
| October 09, 2026 | 498.89M |
| October 08, 2026 | 490.40M |
| October 07, 2026 | 486.48M |
| October 06, 2026 | 477.34M |
| October 05, 2026 | 487.14M |
| October 02, 2026 | 483.87M |
| October 01, 2026 | 485.18M |
| September 30, 2026 | 505.10M |
| September 29, 2026 | 489.75M |
| September 28, 2026 | 490.40M |
| September 25, 2026 | 495.63M |
| September 24, 2026 | 508.69M |
| September 23, 2026 | 511.30M |
| September 22, 2026 | 555.70M |
| September 21, 2026 | 541.99M |
| Date | Value |
|---|---|
| September 18, 2026 | 541.34M |
| September 17, 2026 | 542.64M |
| September 16, 2026 | 532.85M |
| September 15, 2026 | 539.38M |
| September 14, 2026 | 548.52M |
| September 11, 2026 | 551.78M |
| September 10, 2026 | 568.76M |
| September 09, 2026 | 572.03M |
| September 08, 2026 | 592.92M |
| September 04, 2026 | 613.17M |
| September 03, 2026 | 607.94M |
| September 02, 2026 | 626.23M |
| September 01, 2026 | 605.98M |
| August 31, 2026 | 600.76M |
| August 28, 2026 | 599.45M |
| August 27, 2026 | 603.37M |
| August 26, 2026 | 608.60M |
| August 25, 2026 | 626.88M |
| August 24, 2026 | 609.90M |
| August 21, 2026 | 611.53M |
| August 20, 2026 | 589.33M |
| August 19, 2026 | 632.10M |
| August 18, 2026 | 604.68M |
| August 17, 2026 | 600.76M |
| August 14, 2026 | 585.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.10M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Fulcrum Therapeutics, Inc. | 280.73M |
| Definium Therapeutics, Inc. | 4.793B |
| LeonaBio, Inc. | 45.60M |
Market Cap Related Metrics
| PE Ratio | 45.51 |
| PS Ratio | 1.543 |
| Price to Book Value | 0.8479 |
| Price | 7.30 |
| Earnings Yield | 2.20% |
| Normalized PE Ratio | 33.36 |